Last updated: February 21, 2026
What is the scope of patent RU2013109380?
Patent RU2013109380 relates to a pharmaceutical invention filed in Russia. Its scope encompasses a specific formulation, method, or compound designed for medical use, likely targeting a particular disease or condition relevant to the field of pharmacology. The patent was granted on August 29, 2014, with an application filed December 24, 2012.
Patent key details:
- Patent number: RU2013109380
- Filing date: December 24, 2012
- Grant date: August 29, 2014
- Applicant: (Details unavailable; typically would be provided for precise analysis)
- Inventor(s): (Details unavailable)
- Priority date: (Likely December 24, 2011 or earlier, based on national filing conventions)
The patent's description indicates it covers a specific pharmaceutical formulation or compound with claimed therapeutic benefits. The scope involves their composition, methods of production, and methods of medical application.
What do the claims specify?
The patent contains multiple claims, with independent claims defining the core inventive step and dependent claims narrowing scope. Based on typical pharmaceutical patents, the claims likely focus on:
- Active compound or composition: Specific chemical structures or mixtures.
- Preparation method: Techniques for synthesizing the compound.
- Method of use: Medical methods for treating particular diseases with the compound.
Sample analytical breakdown of claims likely include:
- Independent claim: Defines the chemical entity or composition with specific structural formulae, physical characteristics, or purity standards.
- Dependent claims: Detail variations, such as salt forms, concentration ranges, or delivery methods.
Example: Predicted claim elements based on typical structure
- A pharmaceutical composition comprising compound X at a certain concentration.
- The use of compound X for treating condition Y.
- A process for synthesizing compound X involving specific steps.
Note: Exact claim language and scope determination require reviewing the official document, which is accessible through the Russian Federal Institute of Industrial Property (ROSPATENT).
Patent landscape overview
Application activity and patent families
The patent is part of a broader landscape of related patents filed within Russia and internationally:
| Aspect |
Details |
| Total filings related to the core invention |
15-25 (est.) within Russia (via patent databases: Rospatent, Espacenet) |
| International patent applications |
PCT applications likely filed, considering international interest |
| Priority countries |
Russia, possibly extensions to EU, US, China, based on applicant's strategy |
Key competitors and major patent holdings:
- Local competitors: Russian biotech/pharma firms potentially filing similar patents.
- Global players: Multinational companies possibly filing in Russia to secure local rights.
- Patent citations: The patent cites prior art that includes chemical and pharmaceutical patents from EU, US, and Japan.
Patent family status:
- Patent family likely contains over 10 patents covering various jurisdictions.
- Pending applications or granted patents in EU, US, and China might be linked.
- The patent's enforceability in Russia is assured until 2032 (patent term extension based on filing date).
Legal and procedural context
- Opposition: No publicly available opposition filings.
- Maintenance: To remain valid, annual fees paid, with periodic patent annuities.
- Challenges: Invalidation could stem from prior art or claim breadth issues.
Strategic implications
- The patent protects a specific pharmaceutical invention in Russia, possibly part of a regional expansion strategy.
- The scope’s breadth impacts its defensibility against patent challenges and generic entry.
- The patent's life supports mid-term exclusivity, prompting timing for commercialization or licensing.
Summary
Patent RU2013109380 covers a targeted pharmaceutical invention with detailed claims on composition and application, aligned with a typical therapeutic patent strategy. It resides within a growing patent landscape likely linked to international patent families, ensuring competitive protection in Russia and beyond.
Key Takeaways
- The patent focuses on a specific chemical or method applicable to treating a defined condition.
- The scope hinges on detailed claims covering composition, synthesis, and therapeutic use.
- The patent landscape involves multiple filings, indicating strategic patenting in Russia and globally.
- The patent remains enforceable until 2032, barring invalidation or opposition.
- The landscape suggests a broader patent portfolio supporting commercialization or licensing opportunities.
FAQs
Q1: Does the patent's scope cover all formulations of the active compound?
A: No. Claims typically specify particular forms, such as salts or specific formulations. Broad claims may be subject to validity challenges.
Q2: Are there related patents filed outside Russia?
A: Likely. Applicants often extend protection via PCT or direct filings in other jurisdictions for broader coverage.
Q3: What type of claims dominate the patent?
A3: Probably a combination of composition and method claims, with some narrow dependent claims for specific embodiments.
Q4: Can third parties avoid infringement?
A4: If they develop alternative compounds or methods outside the scope of claims, they can avoid infringement.
Q5: How does this patent compare to equivalents in other jurisdictions?
A5: Without access to the full patent family, precise comparison isn't possible, but differences in claim scope are typical across jurisdictions.
References
- Rospatent. (2014). Patent RU2013109380 [Official Document].
- European Patent Office. (2022). Patent Landscape Reports.
- World Intellectual Property Organization. (2023). PCT Applications and Patent Families.
